Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891554-02-000440
Filing Date
2002-02-06
Accepted
2002-02-06 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 13D/A d27826_13d-a.txt SC 13D/A 7497
  Complete submission text file 0000891554-02-000440.txt   9445
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-33655 | Film No.: 02528901
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O SUNRISE SECURITIES 135 EAST 57TH STREET 11TH FLOOR NEW YORK NY 10022
STONE RICHARD (Filed by) CIK: 0001063028 (see all company filings)